Neurological Stem Cell Treatment Study (NEST)
This innovative stem cell study is the only one of its kind to combine both intravenous and intranasal delivery of autologous bone marrow-derived stem cells—two scientifically supported methods for targeting both the central and peripheral nervous systems. The protocol is open to individuals with a range of neurologic conditions, with the most common including chronic Stroke (CVA), Parkinson’s Disease, Traumatic Brain Injury, Multiple Sclerosis, and Peripheral Neuropathy. Early results are promising: patients with Parkinson’s Disease have reported improvements in balance, facial musculature, reduction of the characteristic mask-like appearance, fine motor control, posture, gait and walking speed, as well as reductions in fatigue, depression, and sleep disturbances.
The procedure is performed on an outpatient basis at the ParkCreek Surgery Center, under the care of board-certified anesthesiologists and an experienced orthopedic surgeon who performs the bone marrow aspiration—a quick and virtually painless process. Patients receive both IV and intranasal administration of their own stem cells to maximize distribution and efficacy. A brief three-night stay is recommended to accommodate preoperative assessment, the day of treatment, and postoperative follow-up. Most patients can safely return home the following day, including by air travel. The total cost of the procedure is $17,000 USD. For more information and detailed clinical trial data, please refer to the official listing on ClinicalTrials.gov (NCT02795052).